Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
Keyword(s):
Keyword(s):
2017 ◽
2019 ◽
Vol 18
(6)
◽
pp. 537-547
◽